BioMI Session
|
Tuesday November 8th |
Innovative technology & biology
Laboratory equipments
Morning session - Chairpersons : Richard Fabre - Gilles Pivert
9.00Introduction
Acquiring innovative equipments: what indicators?
Gilles Pivert, Equipment Management Department, Cochin University Hospital, APHP-Paris, France
9.30
Mass Spectrometry and neo-natal screening for hereditary diseases of the metabolism: updates after publication of the French High Health Authority report
David Chaillan, Ward for Hereditary Diseases of the Metabolism and neo-natal screening, East Hospital Groupment, Biology-Pathology Centre, Bron, France
10.00
The example of Mass Spectrometry (MS) applied to microbiological diagnostics
by bioMérieux
- VITEK MS: innovation applied in routine
Romuald Courtade, Products Manager bioMérieux, Mass Spectrometry (MS), Craponne, France
- Medical impact and output of MS into diagnostics
Orlando Petrini, Director of the Cantonal Institute of Microbiology, Bellinzona, Switzerland
- Organistional impact and Lean 6 Sigma applied to MS
Jean Philippe Brochet, Exalab private clinical laboratory, Bordeaux le Haillan, France
The example of Mass Spectrometry (MS) applied to microbiological diagnostics
by bioMérieux
- VITEK MS: innovation applied in routine
Romuald Courtade, Products Manager bioMérieux, Mass Spectrometry (MS), Craponne, France
- Medical impact and output of MS into diagnostics
Orlando Petrini, Director of the Cantonal Institute of Microbiology, Bellinzona, Switzerland
- Organistional impact and Lean 6 Sigma applied to MS
Jean Philippe Brochet, Exalab private clinical laboratory, Bordeaux le Haillan, France
10.30
Automation of samples treatment in new generation sequencing: application in molecular diagnostics
Yannick Bidet, Auvergne University - Molecular Oncology Laboratory, Jean Perrin Cancer Centre, Clermont-Ferrand, France
Automation of samples treatment in new generation sequencing: application in molecular diagnostics
Yannick Bidet, Auvergne University - Molecular Oncology Laboratory, Jean Perrin Cancer Centre, Clermont-Ferrand, France
11.00
The example of GeneXpert (Cepheid ): a molecular platform perfectly adapted to Clinical Laboratories
Anne Dubouix-Bourandy, The Union Medical Centre, Toulouse, France
The example of GeneXpert (Cepheid ): a molecular platform perfectly adapted to Clinical Laboratories
Anne Dubouix-Bourandy, The Union Medical Centre, Toulouse, France
11.30
Alzheimer disease: biomarkers from biochemistry to molecular biology
Sylvain Lehmann, Laboratory of Biochemistry & Clinical Proteomics, Montpellier University Hospital, France
Alzheimer disease: biomarkers from biochemistry to molecular biology
Sylvain Lehmann, Laboratory of Biochemistry & Clinical Proteomics, Montpellier University Hospital, France
12.00
ADN micro-array as a screening tool - an example of application: HPV screening
Philippe Phamtrong, Bioscience Division, Greiner bio-one
ADN micro-array as a screening tool - an example of application: HPV screening
Philippe Phamtrong, Bioscience Division, Greiner bio-one
